INZY
Price
$0.96
Change
-$0.02 (-2.04%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
66.17M
19 days until earnings call
THRD
Price
$5.14
Change
-$0.01 (-0.19%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
232.29M
14 days until earnings call
Ad is loading...

INZY vs THRD

Header iconINZY vs THRD Comparison
Open Charts INZY vs THRDBanner chart's image
Inozyme Pharma
Price$0.96
Change-$0.02 (-2.04%)
Volume$2.15K
Capitalization66.17M
Third Harmonic Bio
Price$5.14
Change-$0.01 (-0.19%)
Volume$3.38K
Capitalization232.29M
INZY vs THRD Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INZY vs. THRD commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Buy and THRD is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (INZY: $0.98 vs. THRD: $5.15)
Brand notoriety: INZY and THRD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 102% vs. THRD: 65%
Market capitalization -- INZY: $66.17M vs. THRD: $232.29M
INZY [@Biotechnology] is valued at $66.17M. THRD’s [@Biotechnology] market capitalization is $232.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 1 FA rating(s) are green whileTHRD’s FA Score has 1 green FA rating(s).

  • INZY’s FA Score: 1 green, 4 red.
  • THRD’s FA Score: 1 green, 4 red.
According to our system of comparison, THRD is a better buy in the long-term than INZY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 4 TA indicator(s) are bullish while THRD’s TA Score has 4 bullish TA indicator(s).

  • INZY’s TA Score: 4 bullish, 3 bearish.
  • THRD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INZY is a better buy in the short-term than THRD.

Price Growth

INZY (@Biotechnology) experienced а +1.90% price change this week, while THRD (@Biotechnology) price change was +0.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

INZY is expected to report earnings on Aug 12, 2025.

THRD is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
THRD($232M) has a higher market cap than INZY($66.2M). THRD YTD gains are higher at: -49.951 vs. INZY (-64.617). THRD has higher annual earnings (EBITDA): -52.79M vs. INZY (-95.72M). THRD has more cash in the bank: 296M vs. INZY (113M). THRD has less debt than INZY: THRD (3.4M) vs INZY (46.9M). INZY (0) and THRD (0) have equivalent revenues.
INZYTHRDINZY / THRD
Capitalization66.2M232M29%
EBITDA-95.72M-52.79M181%
Gain YTD-64.617-49.951129%
P/E RatioN/AN/A-
Revenue00-
Total Cash113M296M38%
Total Debt46.9M3.4M1,378%
TECHNICAL ANALYSIS
Technical Analysis
INZYTHRD
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 18 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DRCVX4.09N/A
N/A
Comstock Capital Value A
PXINX11.36N/A
N/A
Impax International Sust Econ Inv
SEMTX16.62N/A
N/A
Hartford Schroders Emerging Mkts Eq SDR
TBWAX18.69N/A
N/A
Thornburg Better World International A
VYMYX17.16N/A
N/A
Voya Mid Cap Research Enhanced Index W

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with IGMS. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-4.84%
IGMS - INZY
55%
Loosely correlated
-4.79%
MRSN - INZY
49%
Loosely correlated
+2.39%
BEAM - INZY
49%
Loosely correlated
+3.87%
ERAS - INZY
48%
Loosely correlated
+2.90%
CRNX - INZY
48%
Loosely correlated
+3.55%
More

THRD and

Correlation & Price change

A.I.dvisor indicates that over the last year, THRD has been loosely correlated with INZY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if THRD jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THRD
1D Price
Change %
THRD100%
-0.19%
INZY - THRD
50%
Loosely correlated
-4.84%
NVAX - THRD
42%
Loosely correlated
+19.52%
APGE - THRD
42%
Loosely correlated
+2.93%
ACLX - THRD
38%
Loosely correlated
+0.81%
IGMS - THRD
38%
Loosely correlated
-4.79%
More